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Here we identify the humpty dumpty (humdy)
mouse mutant with failure to close the neural
tube and optic fissure, causing exencephaly
and retinal coloboma, common birth defects.
The humdy mutation disrupts Phactr4, an
uncharacterized protein phosphatase 1 (PP1)
and actin regulator family member, and themis-
sense mutation specifically disrupts binding to
PP1. Phactr4 is initially expressed in the ventral
cranial neural tube, a region of regulated prolif-
eration, and after neural closure throughout the
dorsoventral axis. humdy embryos display
elevated proliferation and abnormally phos-
phorylated, inactive PP1, resulting in Rb hyper-
phosphorylation, derepression of E2F targets,
and abnormal cell-cycle progression. Exence-
phaly, coloboma, and abnormal proliferation in
humdy embryos are rescued by loss of E2f1,
demonstrating the cell cycle is the key target
controlled by Phactr4. Thus, Phactr4 is critical
for the spatially and temporally regulated transi-
tion in proliferation through differential regula-
tion of PP1 and the cell cycle during neurulation
and eye development.
INTRODUCTION
Neurulation is a fundamental morphogenetic process
during vertebrate embryogenesis whereby the neural
plate rolls up to form the neural tube, the embryonic pre-
cursor of the central nervous system (Colas and Schoen-
wolf, 2001). Defects in neural tube closure occur in 1 in
1000 human births, making it the second most common
birth defect (Juriloff and Harris, 2000). Cranial region
neural tube defects are called anencephaly in humans
and exencephaly in mice, and spinal cord neural tube
defects are called spina bifida. The high incidence of
neural tube closure defects reflects the complexity ofDethe process in which there must be tight coordination
of proliferation and differentiation, patterning, cell death,
cell-shape changes, and cell movement. These events
must also be coordinated between the neural tissue
and neighboring ectoderm and mesenchyme (Copp
et al., 2003).
At the time of normal cranial neural closure, there is
regulated proliferation along the dorsal and ventral axis
of the neural tube, with more proliferation in the dorsal
versus the ventral half (Copp et al., 2003). Following neural
closure, proliferation is more uniform along the dorsoven-
tral aspect of the cranial neural tube, but this early differ-
ence in dorsoventral proliferation is now evidenced by
a greater number of differentiated cells in the ventral
neural tube. Although it has been speculated that early
spatially regulated proliferation is critical for proper neural
tube closure and differential proliferation is important in
regulating the timing of neuronal differentiation, it is
unclear what genes are required to achieve this regulation
during development or the fundamental importance of this
regulation in neural closure.
Although no genes have been identified which control
the dorsoventrally regulated proliferation, some mouse
mutants display exencephaly due to excessive cell prolif-
eration throughout the neural tissue. Overexpression of
Notch3 results in an increased number of neuronal
progenitors and exencephaly (Lardelli et al., 1996). Muta-
tions in tumor suppressor genes can cause abnormal
neural proliferation and exencephaly, including a subset
ofp53-deficient embryos (Sah et al., 1995) and a hypomor-
phic mutation in brca1 (Gowen et al., 1996). Heterozy-
gotes of the chromatin remodeling complex, such as
Brg1 and Srg1, are predisposed to exencephaly and
tumors of the nervous system (Kim et al., 2001).
A number of protein kinases have been identified as key
regulators of cell-cycle progression, and specific phos-
phatases counter their activity (Berndt, 2003). Protein
phosphatase 1 (PP1) is a major serine/threonine phospha-
tase that regulates a variety of cellular functions through
interactions with more than 50 different targeting subunits
(Cohen, 2002). PP1 function in the cell cycle is best under-
stood through its regulation of the retinoblastoma protein
Rb. In vitro studies show the catalytic subunit of PP1velopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 87
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 1. Increased Proliferation and Reduced Differentiation in humdy Neural Tube
(A and B) Lateral views of E12.5 wild-type (WT) and humdy (MUT) exencephalic embryos.
(C and D) Whole-mount antineurofilament antibody staining.88 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc.
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Phactr4 Controls Neurulation via Rb/E2F Cell Cycleinteracts with and dephosphorylates Rb, leading to Rb ac-
tivation (Durfee et al., 1993; Tamrakar et al., 2000; Vietri
et al., 2006). Hypophosphorylated Rb binds to and
sequesters E2F transcription factors, inhibiting transcrip-
tion of genes required for the G1/S transition and thus
inhibiting cell-cycle progression. As cells progress
through late G1 and S phase, Rb becomes hyperphos-
phorylated and inactivated by cyclin/cdk complexes
(Pagano and Jackson, 2004; Sherr and Roberts, 2004),
leading to release of E2F and transcription of E2F targets
required for cell-cycle progression. Therefore, regulation
of Rb phosphorylation is critical in cell-cycle control.
Genetic studies have shown PP1 is required for progres-
sion through or exit from mitosis in Aspergillus nidulans
(Doonan and Morris, 1989), fission yeast (Booher et al.,
1989; Ohkura et al., 1989), and Drosophila (Axton et al.,
1990). Because Rb is thought to be a target of PP1, one
important mechanism of PP1-mediated mitotic exit may
involve activation of G1-specific regulators such as Rb.
Treatment of mitotic cell extracts with PP1-specific inhib-
itors inhibits Rb dephosphorylation (Ludlow et al., 1993).
PP1 regulation of Rb is controlled by an inhibitory
phosphorylation on threonine 320 of PP1 that is observed
during M phase and in late G1 through early S (Liu et al.,
1999b). A constitutively active T320A mutant of PP1, but
not wild-type PP1, retains Rb in a hypophosphorylated
and activated state and causes cell-cycle arrest at G1/S
transition. Furthermore, T320A PP1 mutant does not
impede cell-cycle progression in Rb-negative cells, indi-
cating PP1 requires functional Rb to induce growth arrest
(Berndt et al., 1997). This suggests inactivation of PP1
sometime during G1 is required to allow Rb phosphoryla-
tion and initiation of S phase. However, in vivo genetic
evidence for PP1 regulation of Rb during the cell cycle is
still missing. Moreover, an understanding of PP1 functions
in vivo has remained elusive and is complex, as PP1 reg-
ulates many different biological processes and there are
three genes that encode the three forms of PP1 (a, b, g)
in mammals.
To better understand PP1 function, a yeast two-hybrid
screen was performed to identify PP1a-interacting
proteins (Allen et al., 2004). A novel protein strongly
expressed in brain was identified with PP1- and actin-
binding domains at the C terminus, and named phospha-
tase and actin regulator 1 (Phactr1). By sequence
homology, three other family members were identified
(called Phactr2–4). Although Phactr family proteins lack
a consensus PP1-binding sequence (R/K-R/K-hydropho-
bic-X-F/W) defined in other PP1-binding proteins, all four
members show strong conservation of their own PP1-
and actin-binding domains (Allen et al., 2004). However,
the functional relevance of this binding has not beenDevestablished and the in vivo functions of the Phactr family
members are not known.
Although the cellular events during neurulation are well
documented, the mechanisms controlling this complex
process are poorly understood. To gain a better under-
standing of the genes involved in neurulation and the
mechanisms by which they act, we have undertaken
forward genetic screens in mice to identify mutations
that affect neural tube closure (Kasarskis et al., 1998;
Zohn et al., 2005). Following treatment with the chemical
mutagen ethyl nitrosourea (ENU) and screening for reces-
sive mutations that affect embryonic neural tube closure,
we identified a number of genes of which little is known
as to their mechanism of action and which have not
been implicated in neural development. Here we describe
the humdy mouse mutant with defects in closure of the
neural tube and optic fissure. The humdy gene encodes
Phactr4, an uncharacterized member of the Phactr family.
A missense mutation was found in the proposed PP1-
binding domain, and this specifically disrupts binding of
PP1 to Phactr4. This leads to an increase in T320 inhibitory
phosphorylation on PP1 in the ventral neural tube and eye
and disruption of PP1 activity toward its target Rb. This
causes Rb to become hyperphosphorylated and inacti-
vated, leading to derepression of E2F targets. Loss of
Phactr4 function results in shortening of the cell cycle,
an increase in proliferating neural progenitors, and ectopic
cell division and/or cell-cycle exit defects in differentiating
cells of the humdy neural tube and retina. To demonstrate
that the key target of Phactr4/PP1 is the cell cycle, we
generated embryos mutant for both phactr4humdy/humdy
and E2f1. Loss of E2f1, even loss of a single allele, results
in rescue of exencephaly, coloboma, and proliferation/
differentiation defects, providing strong genetic and
functional evidence that the critical target of Phactr4 is
the cell-cycle regulator E2F1. Thus, our studies identify
a critically required pathway from Phactr4 to the in vivo
regulation of PP1 and Rb activity to E2F1 in cell-cycle
control which is necessary for proper neural tube closure
and eye development.
RESULTS
humdyMutant Mouse Embryos Display Neural Tube
and Eye Defects
To study neurulation in an unbiased way, we performed
ENU mutagenesis screens for recessive mutations in
mice which cause neural tube closure defects (NTD)
(Kasarskis et al., 1998; Zohn et al., 2005). From this
screen, we isolated the humpty dumpty (humdy) mutant
mouse line that displays extensive cranial neurulation
and eye defects (Figures 1A–1D and 2A–2H). To(E–V) Cross-sections of wild-type and humdy cranial neural tube detected for Shh protein in the floor plate (E and F); TUNEL staining for apoptotic cells
(G andH); phospho-ERM, cortactin, and phalloidin (I–N); and proliferationmarkers Ki67 ([O, P, S, and T]; late G1-Mphase) and PH3 ([Q, R, U, and V]; M
phase).
(W–Z) The neuronal differentiation marker TuJ1 (green in [W] and [X]; Ki67, red) and cell-cycle inhibitor p27 (Y and Z) show reduced differentiation in
humdy neural tube. Brackets indicate ventral side of neural tube, dotted lines outline the neural tube, and double dotted lines in (S), (T), (Y), and (Z)
highlight differentiated cells. Embryonic age is indicated in each panel.elopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 89
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 2. Increased Proliferation and Abnormal PP1 and Rb Phosphorylation in humdy Retina
(A–H) Wild-type (WT) and humdy (MUT) eye showing expanded retinal pigment epithelium (B, D, and H) and retinal coloboma ([D and F], red arrow) in
humdy eye.
(G and H) Histology of eye in cross-section from wild-type and humdy E14.5 embryos showing retina overgrowth.
(I–X) Cross-sections of wild-type and humdy eye detected with proliferationmarker PH3 ([I–L], green; M phase), cell-cycle inhibitor p27 (M andO), and
neuronal differentiation marker TuJ1 ([N and P], green) showing increased proliferation and reduced differentiation in humdy retina.
(Q and S) Anti-PT320PP1 antibody shows increased number of cells with inactive PP1 in humdy eye.90 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc.
Developmental Cell
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were examined from embryonic day (E) 8.5 to E16.5. By
E9.25, mutant embryos can be distinguished by their
failure to close the cranial neural tube. About 15% of
humdy homozygous mutant embryos exhibit severe
exencephaly, along with a wavy spinal neural tube and
a shortened anterior/posterior body axis, and they die
around E10.5 (data not shown). The remaining homozy-
gous mutant embryos exhibit complete exencephaly
from the forebrain to hindbrain (Figures 1A and 1B).
Most humdy embryos die by E14.5, but a few survive to
birth and die shortly thereafter. Approximately 8% (7/93)
of heterozygous embryos display a midbrain region-
specific exencephaly (data not shown), indicating an in-
completely penetrant dominant effect.
humdy embryos also have eye defects. Homozygous
mutant embryos display overgrowth of the neural retina
and retinal pigment epithelium (RPE) (Figures 2A–2D,
2G, and 2H). The primordium of the eye initiates from
the neuroepithelium of the ventral diencephalon. It evagi-
nates to form optic vesicles and subsequently invaginates
to form the optic cup. The point at which the laterally grow-
ing edges of the optic cup fuse is called the optic fissure
(Chow and Lang, 2001). Failure of optic fissure closure
can lead to coloboma, which occurs in 1 in 10,000 human
births (Weston et al., 2003). humdy embryos also display
coloboma at E12.5 and E16.5 (Figures 2C–2F).
Increased Proliferation and Decreased
Differentiation in humdy Neural Tube and Retina
To distinguish the underlying cause of exencephaly, we
used molecular markers to examine a number of cellular
events during neurulation. Patterning and apoptosis
were not obviously altered in humdy mutant neural tube
(E8.5–E11.5) or retina (E12.5) (Figures 1C–1H; see Figures
S1 and S2 in the Supplemental Data available with this ar-
ticle online). There was no apparent change in cytoskeletal
architecture, cell morphology, neuroepithelial integrity, or
actin localization in the humdy neural tube (Figures 1I–1N;
phospho-ERM, cortactin, phalloidin staining). There was
no defect in medial hinge point formation, and dorsolateral
hinge point formation was inconsistently affected, with
some samples showing a defect and others no defect
(e.g., Figure 1P and 6B, respectively).
Overgrowth of brain tissue, neural retina, and RPE sug-
gested proliferation is disrupted in humdy neural tube and
eye. Proliferation in the presumptivemid-/hindbrain region
was first analyzed with Ki67 antibody, a late G1-M phase
marker. At E9.5, in wild-type embryos during cranial neural
closure there is spatially regulated proliferation, with more
proliferation in the dorsal than ventral neural tube
(Figure 1O). In the humdy cranial neural tube, however,
this regulation was disrupted with greatly increased prolif-
eration ventrally (Figure 1P), more similar to proliferation
normally seen dorsally. In wild-type embryos at E10.5 afterDeneurulation, proliferation is more uniform along the dorso-
ventral axis (Figure 1S). In E10.5 humdy cranial neural
tube, the number of Ki67-positive cells was greatly in-
creased both ventrally and dorsally (Figure 1T). Examina-
tion of cells in M phase using an anti-phospho-histone H3
(PH3) antibody also showed abnormal proliferation in the
humdy ventral neural tube at E9.5 and then in both the dor-
sal and ventral regions at E10.5 (Figures 1Q, 1R, 1U, and
1V). The number ofmitotic cells was quantified (see Exper-
imental Procedures) and found to be increased 2-fold
(statistically significant; p value = 0.046) in the E9.5 humdy
ventral neural tube. Moreover, at this stage there was no
longer a significant difference in proliferation between
the dorsal and ventral regions.
As differentiation is tightly linked to exit from the cell cy-
cle, twomarkers of neuronal differentiation, TuJ1 and p27,
a cell-cycle inhibitor, were examined. Starting by E9.5 in
the wild-type cranial neural tube, proliferating neuronal
progenitors in the ventricular zone begin to exit the cell cy-
cle, differentiate, and migrate laterally (Figures 1W and
1Y). This pattern of differentiation is particularly evident
in the ventral neural tube both at E9.5 and E10.5 and cor-
relates with the domain of reduced proliferation at E9.5. In
the humdy cranial neural tube at E9.5 and E10.5, abnormal
differentiation was observed as the number of TuJ1- and
p27-positive cells were reduced, particularly in the ventral
half (Figures 1X and 1Z), corresponding to the region of
abnormal proliferation.
Defects in morphogenesis of the humdy eye were also
related to increased proliferation and decreased differen-
tiation. At E12.5 and E14.5, there were significantly more
PH3-positive mitotic cells (Figures 2I–2L; average differ-
ence between wild-type and mutant retina is 4.8; p =
0.042) and fewer p27-positive cells and differentiated neu-
rons (Figures 2M–2P) in the humdy neural retina compared
to wild-type. Taken together, this indicates the neural tube
and retinal defects in humdy mutant embryos are due to
misregulation of proliferation and differentiation. Cranial
neural tube closure normally occurs by E8.5–E9.5 at the
time of spatially restricted proliferation along the dorso-
ventral axis. humdyNTD is associated with locally deregu-
lated proliferation in the ventral aspect of the neural tube.
Although this differential proliferation has been noted
previously, the humdy mutant provides evidence that
this regulated proliferation is necessary for cranial neural
tube closure.
Decreased Cell-Cycle Length and Disrupted
Cell-Cycle Exit in humdy Mutants
To explore further the defects in cell proliferation and dif-
ferentiation, we quantified the number of progenitor to
differentiated cells using anti-Sox9 and -p27 antibodies, re-
spectively. This showed a >2-fold increase in the ratio of
proliferating neural progenitors to differentiated cells in
the humdy hindbrain region (Figures 3A–3C). Conversely,(R and T) Anti-S608Rb antibody shows increased number of cells with inactive Rb in humdy eye.White dots in (Q)–(T) mark neural progenitor cells with
inactive PP1 or phosphorylated Rb.
(U–X) Wild-type and humdy eyes detected with anti-MCM2 (U and V) or anti-BrdU (W and X) antibodies.velopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 91
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 3. Shortened Cell Cycle and Cell-Cycle Exit Defects in humdy Neural Tube
(A and B) Sox9-positive neural progenitors (pink) are increased and p27-positive differentiated neurons (green) are reduced in humdy neural tube at
E10.5.
(C) Quantification of the ratio of progenitors to differentiated neurons.
(D–I) Cumulative BrdU labeling shows shortening of neural progenitor cell cycle in humdy embryos at E10.5. (D–G) BrdU labeling of neural progenitors
(red) after indicated time of incubation.
(J–L) BrdU labeling and TuJ1 staining show cell-cycle exit defects and/or abnormal cell-cycle entrance in humdy embryos.
(M and N) TuJ1-positive neurons are increased in number in E12.5 humdy embryos. Wild-type (WT) and humdy (MUT).92 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc.
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markers of differentiation (Figures 1W–1Z and 3A–3C; eye,
Figures 2M–2P), indicating a defect in differentiation, and
subsequently this leads to significantly increased neuro-
genesis (Figures 3M and 3N).
To determine whether the increase in number of neural
progenitors is related to a change in cell-cycle length, we
performed cumulative BrdU incorporation studies. This
showed the total cell-cycle length minus S phase length
(Tc  Ts) was 7 hr in the wild-type E10.5 cranial neural
tube, whereas it was shortened to 6 hr in humdy mutants
(Figures 3D–3I). Thus, the Humdy gene is critical in regu-
lating the pace of the cell cycle within neural progenitors.
We also found the humdy mutation affects cell-cycle
exit. BrdU labeling showed proliferating cells within the
domains of differentiated cells in humdy neural tube and
retina (Figures 2W, 2X, 3J, and 3K). This ectopic cell divi-
sionwas also shown by coexpression of an earlymarker of
differentiated neurons (TuJ1) and a proliferation marker
(BrdU; Figure 3L). Thus, some mutant cells which have
turned on markers of differentiated neurons and moved
out of the proliferative zone reenter the cell cycle and/or
do not properly exit the cell cycle. The shortened cell
cycle, increase in number of neural progenitors, and
ectopic cell division indicate the Humdy gene is critically
required in regulation of cell-cycle length and cell-cycle
exit.
The Humdy Gene Encodes Phactr4,
an Uncharacterized Phosphatase and Actin
Regulator Protein
The humdy mutation was mapped to a 2 Mb region on
mouse chromosome 4 using strain-specific polymor-
phisms and meiotic recombination mapping
(Figure 4A). In the region was an annotated but function-
ally uncharacterized gene called Phactr4. Phactr4 is re-
lated by sequence homology to Phactr1, which was
identified by its interaction with PP1 and actin (Allen
et al., 2004). As PP1 plays a role in regulating prolifera-
tion, Phactr4 was a good candidate for a regulator of
embryonic proliferation. cDNAs of Phactr4 from wild-
type and humdy mutant embryos were isolated and
sequenced. This identified a missense mutation which
changes arginine (Arg) at amino acid 650 to proline
(Pro) in the conserved C-terminal region (Figure 4B;
Figure S3). To confirm the Phactr4 mutation is responsi-
ble for the humdy phenotype, we obtained a second
allele of Phactr4. BayGenomics embryonic stem cell
clone RRA075 contains a gene-trap insertion in the sec-
ond intron, resulting in fusion of the first five amino acids
of Phactr4 in-frame with a b-galactosidase and neomy-
cin phosphotransferase cassette. In a complementation
cross, embryos transheterozygous for the humdy and
gene-trap alleles display exencephaly (Figure 4C), con-
firming Phactr4 identification. However, homozygous
gene-trap allele embryos often have less severe pheno-
types than humdy embryos, and indeed we detect
some residual Phactr4 protein in sections of Phactr4
gene-trap mutant embryos (data not shown).DevPhactr4 Interacts with PP1 and Actin, and the
Missense Mutation in humdy Disrupts PP1 Binding
Phactr1, the first member of this family, was identified in
a yeast two-hybrid screen by its interaction with PPIa
and actin, and these binding sites mapped to the C termi-
nus (Allen et al., 2004). However, the functional signifi-
cance of this interaction with PP1 is unknown or whether
it affects PP1 activity. Phactr4 displays a high level of
amino acid sequence homology to Phactr1, especially in
the C terminus (Figure S3). Moreover, the humdy point
mutation is within the proposed PP1-binding domain.
We generated a polyclonal antibody to Phactr4 and
showed the amino acid change does not affect stability
or localization of Phactr4humdy protein in mutant embryos
(Figures 5J and 5M). To determine whether mouse
Phactr4 interacts with PP1 andwhether the point mutation
specifically disrupts PP1 binding, we first tested binding in
a yeast two-hybrid assay. The humdy mutant construct
interacted much more weakly with PP1a than wild-type
Phactr4 (Figure 4D). We then tested interaction with PP1
and determined whether actin binding was affected by
coimmunoprecipitation of endogenous PP1 and actin
with Myc-tagged wild-type or humdymutant Phactr4 con-
structs expressed in 293T cells (Figures 4E and 4F). This
showed Phactr4humdy binds actin similarly to wild-type
Phactr4 (Figure 4E). Wild-type Phactr4 strongly binds
PP1a; however, the Phactr4humdy mutation dramatically
disrupts PP1a binding, even in this overexpression assay
(Figure 4F). Reciprocal coimmunoprecipitation using anti-
PP1a to pull down Phact4 also showed severely disrupted
interaction (Figure 4F). Possible interactions of the Phactr
family with other PP1 family members have not been
tested. Figure 4F shows Phactr4 interacts with PP1b
(also called d) and PP1g, and these interactions are also
significantly reduced by the humdy mutation. Thus, the
ENU-induced humdy mutation results in a unique allele,
generating a stable protein with a specific defect in PP1
binding.
Phactr4 Is Expressed in Neural Tube and Retina
To determine whether Phactr4 is expressed in a pattern
consistent with regulation of neural and eye development,
Phactr4 RNA expression was assessed during embryonic
development (E8.5–E10.5) using both a digoxygenin-
labeled Phactr4 antisense probe (Figures 5C–5F) and
whole-mount LacZ staining to detect the gene-trap allele
(Figures 5A and 5B). Phactr4 is most strongly expressed
in neural tissue (Figures 5A–5C). Interestingly, and in
accordance with the humdy phenotype, Phactr4 is
expressed in a dynamic pattern during neurulation. From
E8.5 to E9.5, the period of cranial neural closure and spa-
tially regulated proliferation, Phactr4 is expressed strongly
in the ventral region of the cranial neural tube (Figure 5D),
the region of abnormal proliferation in humdy mutants
(Figures 1O and 1P). By E10.5, Phactr4 is expressed
more uniformly along the dorsal and ventral aspects of
the cranial neural tube (Figure 5E), the time when ectopic
proliferation is observed throughout the dorsoventral
aspect of the humdy neural tube (Figures 1S and 1T).elopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 93
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 4. The humdy Gene Encodes Phactr4, and the phactr4humdy Mutation Disrupts Interaction with PPI but Not Actin
(A) Genetic map of the humdy interval on mouse chromosome 4. Polymorphic markers and number of recombination events based on carriers are
shown.
(B) Missense mutation from G to C resulting in Arg-to-Pro amino acid change in the conserved C terminus of the Phactr4 gene.
(C) The gene-trap phactr4 allele fails to complement the phactr4humdy allele (arrow indicates exencephaly).
(D) Yeast two-hybrid assay. Yeast cells cotransfected with PP1-GAL4 DNA-binding domain and either wild-type or humdymutation GAL4 activation
domain and selected on minus leucine and tryptophan medium (SD-LW). Selection for interaction on medium lacking histidine (SD-LHW).
(E and F) Interaction of Phactr4 with endogenous actin and PP1. Immunoprecipitation with anti-Myc beads of wild-type Phactr4 or Phactr4humdy
followed by western blot analysis with anti-actin (E) or anti-PP1a, b, g ([F], top row) antibodies. Immunoprecipitation with anti-PP1a followed by west-
ern blot analysis with anti-Myc antibody to detect interaction with wild-type Phactr4 or Phactr4humdy ([F], lower row). Phactr4humdy binds actin, but
binding to all PP1 proteins is severely disrupted.Phactr4 is also expressed in the neural retina and lens (Fig-
ures 5F and 5H).
Subcellular Localization of Phactr4, F-Actin, and PP1
in the Embryonic Neural Tube
Phactr1 is localized in the cytoplasm, whereas Phactr3 is
in the nucleus (Allen et al., 2004; Sagara et al., 2003). To
determine the in vivo subcellular localization of Phactr4,
we used our polyclonal antibody to Phactr4: specificity
shown bywestern blot of E10.5 embryo lysates and immu-
nohistochemistry of E12.5 eye (Figures 5G–5I). Immuno-
histochemistry on E9.5 wild-type cranial neural tube
showed Phactr4 was strongly expressed in the cytoplasm
but not the nucleus (Figure 5J), similar to subcellular
localization of Phactr1 (data not shown). Phactr4 also94 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inccolocalized with F-actin (Figures 5J–5L), consistent with
its ability to bind actin by coimmunoprecipitation. In the
humdy neural tube, the mutant protein is still expressed
and localized to the cytoplasm (Figure 5M), in accord
with its retained ability to bind actin. In wild-type, PP1 is
localized more strongly in the cytoplasm than in the
nucleus (Figure 5N). However, in the humdy neural tube
there was a slight but consistent shift in PP1 localization
to the nucleus, as assayed by immunohistochemistry
(Figure 5O) and nuclear/cytoplasmic fractionation
(Figure 5S). Phactr1 binds at least PP1a, and Phactr1 is
localized to the cytoplasm and expressed in neural tissue
similarly to Phactr4. Redundancy between Phactr family
members may explain why PP1 localization is not dramat-
ically shifted in humdy mutants and why abnormal.
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Phactr4 Controls Neurulation via Rb/E2F Cell Cycleproliferation occurs specifically in the hindbrain and retina
of humdy embryos, although Phactr4 is expressed more
broadly in the central nervous system. To explore further
the ability of Phactr4 to affect subcellular localization of
PP1, a gain-of-function studywas performed by transfect-
ing Myc-tagged wild-type Phactr4 into HeLa cells. In
untransfected cells, PP1 predominantly localized to the
nucleus (Figure 5P), whereas in transfected cells there
was a shift of PP1 into the cytoplasm (Figures 5Q and
5R). These loss- and gain-of-function experiments sup-
port the idea that Phactr4 binds PP1 and retains it in the
cytoplasm, where Phactr4 protein is normally localized.
Taken together with our data on a biochemical interaction
between Phactr4 and PP1 (Figures 4D and 4F), this indi-
cates a functional interaction between cytoplasmic PP1
and Phactr4 within the embryonic neural tube, the tissue
affected in humdy mutants.
Inhibitory Phosphorylation of PP1 Is Abnormally
Increased in phactr4humdy/humdy Neural Tube
and Retina
Abnormal cell-cycle regulation in humdy mutant neural
tube and retina and disruption in PP1 binding suggested
PP1 activity might be defective in humdy embryos. PP1
activity with respect to Rb and the cell cycle is regulated
by an inhibitory phosphorylation (T320) on PP1 (Berndt
et al., 1997). Thus, we examined inhibitory phosphoryla-
tion of PP1 using an anti-PT320PP1 antibody in vivo. First,
we found PP1 T320 phosphorylation is spatially regulated
in the E9.5 wild-type neural tube with more cells express-
ing phospho-T320PP1 dorsally (Figure 6A), in accord with
differential proliferation at this stage. Second, in humdy
E9.5 ventral neural tube and E12.5 neural retina, PP1
T320 phosphorylation was abnormally increased com-
pared to wild-type (Figures 2Q, 2S, 6A, and 6B), corre-
sponding to regions of misregulated proliferation. Thus,
Phactr4 interaction with PP1 is required in vivo to regulate
the state of inhibitory phosphorylation of PP1 and hence
PP1 activity with regard to cell-cycle regulation.
Rb Is Abnormally Phosphorylated and E2F
Target Expression Is Abnormally Increased
in phactr4humdy/humdy Neural Tube and Retina
In terms of cell-cycle regulation, in vitro studies have
shown that all three isoforms of PP1 interact with and de-
phosphorylate Rb (Vietri et al., 2006; Rubin et al., 2001).
PP1 regulates Rb-mediated cell-cycle arrest and control
at the G1/S transition by dephosphorylating and activating
Rb (Ceulemans and Bollen, 2004). Phosphorylation of
T320 of PP1 inhibits its phosphatase activity so that PP1
can no longer dephosphorylate Rb. Consequently, hyper-
phosphorylated Rb is unable to inhibit cell-cycle progres-
sion. The abnormal S phase entry defects in humdy
embryos (Figures 1P, 1T, 1X, and 3K) and disruption in
PP1 activity (Figures 2S and 6B) suggested dephosphor-
ylation of Rb might be defective. We therefore examined
Rb phosphorylation at S608 and S807/811, as phosphor-
ylation of these sites inactivates Rb and leads to cell-cycle
progression. Phosphorylation of these sites was abnor-Demally increased in the humdy ventral neural tube at E9.5
and was present more broadly at E10.5 (Figures 6C–6F),
correlating with increased Ki67-positive neuronal progen-
itors (Figures 1O, 1P, 1S, and 1T). In the humdy retina, the
number of neural progenitors expressing phospho-
S608Rb was also increased relative to wild-type
(Figure 2R), and this corresponded to cells in which PP1
was phosphorylated and inhibited (Figures 2S and 2T).
Thus, mutation of the PP1 binding site in Phactr4 results
in decreased PP1 phosphatase activity and increased
Rb phosphorylation at key regulatory serines in vivo.
Growth suppression by Rb is achieved by its ability to
bind E2F and histone deacetylase and repress E2F target
genes required for cell-cycle progression (Cobrinik, 2005;
Dimova and Dyson, 2005). E2F binds primarily to the
spacer region of Rb, but binding also seems to require
the C terminus of Rb (Adams, 2001). Phosphorylation at
the spacer or C terminus disrupts Rb/E2F complexes,
leading to derepression of E2F activity (Brown et al.,
1999). Thus, we examined whether an E2F target was
abnormally regulated in humdy mutants using anti-
MCM2 antibody. Indeed, MCM2 was increased and
expressed more broadly in humdy neural tube and retina
(Figures 2U, 2V, 6G, and 6H), similar to disruption of the
cell cycle and excess proliferation.
humdy Phenotype and Proliferation Defect Are
Rescued by Loss of E2f1
Next, we undertook a genetic experiment to conclusively
demonstrate that the primary defect in humdy mutants is
due to misregulation of the cell cycle through abnormally
increased E2F activity. The hypothesis is, if Phactr4-PP1
defects are due to misregulated E2F activity, then a
decrease in E2F function should allowmore normal devel-
opment. We tested E2F1, as cell-cycle defects in the cen-
tral nervous system of Rb/mice can be rescued by loss
ofE2f1 (Tsai et al., 1998). Dramatically, phactr4humdy/humdy;
E2f1/ embryos are rescued, as evidenced by complete
(n = 3/5) or partial (n = 2/5) rescue of exencephaly and by
essentially wild-type expression ofmarkers of proliferation
and differentiation within the cranial neural tube (Figures
6I–6L; compare with Figures 1S, 1T, 1Y, 1Z, 3J, and 3K),
as well as MCM2 expression (compare Figure 6O to Fig-
ures 6G and 6H). Even more intriguingly, loss of one allele
of E2f1 is sufficient to completely rescue exencephaly
(Figures 6M and 6N; 7 complete rescue, 6 partial rescue
of 13 total). Coloboma is also rescued by loss of E2f1
(data not shown). Thus, although it was possible that
Phactr4 and PP1 could have other critical targets in the
defective tissues, this rescue provides very strong genetic
and functional evidence that the key target of Phactr4
during neurulation and eye development is the cell cycle
through its regulator E2F1.
DISCUSSION
Here we identify a mutation in mouse Phactr4 that specif-
ically disrupts PP1 binding, leading to an inhibitory phos-
phorylation of PP1. This decreases the ability of PP1 tovelopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 95
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Phactr4 Controls Neurulation via Rb/E2F Cell Cycledephosphorylate and activate Rb and leads to abnormal
E2F activity and dramatically increased proliferation within
the cranial neural tissue and the neural retina, causing ex-
encephaly and retinal coloboma. The humdy phenotypes
are rescued by loss of E2f1 function, hence establishing
a genetic and biochemical pathway from Phactr4 to direct
control of the cell cycle during critical aspects of embryo-
genesis.
Phactr4 Controls Cell-Cycle Progression
by Regulating Rb and E2F1 Function
humdy mutants display exencephaly and coloboma and
severe cell-cycle defects: a shortened cell cycle, an inabil-
ity of cells to properly exit the cell cycle, a substantial
increase in the ratio of proliferating to differentiated cells,
and increased neurogenesis at later stages. The dramatic
rescue of the humdy phenotype by loss of E2f1, even
a single allele, is particularly intriguing, as E2f1/ mice
are viable and fertile and hence only upon mutation of
Phactr4 is a strong requirement for E2F1 in regulation of
the in vivo cell cycle revealed. These studies conclusively
show that disruption of the cell cycle leads to the morpho-
logical and molecular defects observed in humdy
mutants.
Our data support and provide in vivo evidence for
a connection between PP1 and control of Rb phosphory-
lation. To further tie this pathway together, we showed the
phactr4 phenotypes are rescued by loss of E2f1. Rb is the
best-known regulator of E2F1 function and, indeed, we
found Rb is normally hypophosphorylated in the ventral
neural tube at E9.5 and this spatial regulation is disrupted
in humdymutants. In the wild-type E9.5 neural tube, there
is complete concordance between the domain of Phactr4
expression in the ventral neural tube with active PP1 and
hypophosphorylated Rb. In the E9.5 humdy ventral neural
tube, PP1 function is inhibited and Rb is hyperphosphory-
lated. A day later, after neural closure, Phactr4 is normally
expressed throughout the ventricular zone of the cranial
neural tube, and in humdy mutants, Rb is hyperphos-
phorylated throughout the expanded ventricular zone.
This later defect in Rb phosphorylation could be a second-
ary consequence of the misregulated cell cycle. However,
the earlier defect in Rb phosphorylation is highly corre-
lated to the pattern of Phactr4 and PP1 activity and there-Dfore is likely a primary defect. In the humdy eye, we also
established a tight correlation between PP1 inactivation
and Rb hyperphosphorylation. In both the humdy neural
tissue and eye, we observe ectopic transcription of the
E2F target, MCM2, and abnormal cell-cycle progression
at the G1/S transition, and these defects are rescued by
loss of E2f1, a direct target of Rb. Thus, loss of the
upstream regulator of Rb (Phactr4) is compensated for
by loss of the downstream effector of Rb (E2F1), allowing
normal neural and eye development.
Phactr4 localizes to the cytoplasm in both wild-type and
humdymutants, most likely through its binding to the actin
cytoskeleton. One model for Phactr4 function is that
Phactr4 helps retain PP1 in the cytoplasm, through asso-
ciation of Phactr4 with the actin cytoskeleton. Indeed,
loss- and gain-of-function studies show Phactr4 regulates
the cytoplasmic/nuclear distribution of PP1. We propose
that during the G1 phase, PP1 translocates to the nucleus
in a regulated manner, where it dephosphorylates and
activates Rb as well as perhaps other cell-cycle regula-
tors. In the humdy neural tube and retina, Phactr4 no lon-
ger binds PP1, which allows free PP1 to translocate into
the nucleus in an unregulated manner and become inacti-
vated by nuclear inhibitors, leading to abnormal cell-cycle
progression in humdy embryos.
However, humdy mutant cell-cycle defects and embry-
onic phenotypes are more severe than those in Rb null
embryos. An intriguing possibility for the more severe
defect is that Phactr4 may control the activity of multiple
regulators of cell-cycle progression: both Rb-dependent
and Rb-independent pathways. One possibility is that
Phactr4 controls activity of the Rb gene family: Rb,
p107, and p130. Future experiments are required to
determine whether the Rb family as a whole is regulated
by Phactr4. The Rb family proteins have structural similar-
ities in the pocket region important for binding to E2F fam-
ily members (Mulligan and Jacks, 1998), and genetic inter-
action studies between Rb family members in mice
suggest redundant roles. Indeed, some of the phactr4
phenotypes are similar to Rb or Rb family double or triple
mutants. Rb/p107 double knockout embryos die earlier in
embryogenesis than single knockouts and with more
severe cell-cycle defects (Lee et al., 1996). Embryonic
fibroblasts deficient in Rb/p107/p130 show a shorter cellFigure 5. Phactr4 Gene Expression and Subcellular Localization of Phactr4 and PP1
(A and B) Whole-mount LacZ staining of Phactr4+/gene-trap embryos.
(C–F) Section in situ of wild-type embryos with antisense probe for Phactr4 showing strong expression in neural tube and neural retina (NR; L, lens).
(D and E) Phactr4 is expressed dynamically, first in the ventral neural tube during neurulation stage E9 (D), then ubiquitously throughout the dorso-
ventral neural tube at E10.5 ([E]; dorsal at top in [D] and [E]).
(G) Western blot of E10.5 wild-type embryo lysate detected with anti-Phactr4 antibody.
(H and I) Immunofluorescence of E12.5 wild-type eye detected with anti-Phactr4 antibody (H) or preimmune serum (I).
(J–M) Confocal images (1003) showing subcellular localization of Phactr4 and F-actin in wild-type (J–L) and humdy (M) neural tube at E9.5. Nucleus is
visualized with DAPI. Phactr4 is strongly localized in the cytoplasm, where it colocalizes with F-actin, but not the nucleus, and is properly localized in
the humdy mutant.
(N and O) Cross-sections of E9.5 ventral neural tube with PP1a immunostaining. PP1 is expressed strongly in the cytoplasm and more weakly in the
nucleus of wild-type embryos, and localization is slightly shifted to the nucleus in humdy embryos.
(P–R) Immunofluorescence of HeLa cells with PP1a (red) and Myc staining (green). (P) Nontransfected cell.
(Q and R) Myc-tagged wild-type Phactr4 transfected cell.
(S) Nuclear/cytoplasmic fractionation showing subtle but consistent shift of PP1 to the nucleus in humdy neural tube.evelopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 97
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 6. Abnormal Phosphorylation of PP1 and Rb in humdyNeural Tube and Rescue of Proliferation Defect in phactr4humdy/humdy
by Loss of E2f1
(A–H) Cross-sections of wild-type (WT) and humdy (MUT) neural tube detected with anti-PT320PP1 (A and B), anti-phospho-specific Rb (C–F), or anti-
MCM2 (G and H) antibodies.
(I–L and O) Cross-sections of cranial neural tube of phactr4humdy/humdy; E2f1/ embryos stained with anti-Ki67 (I), -p27 (J), -TuJ1 (K), -BrdU (L),
and -MCM2 (O) antibodies. Defects of proliferation, differentiation, and E2F target expression in humdy embryos are rescued by loss of E2f1 and
are comparable to wild-type (see Figures 1, 6G, and 6H).
(M and N) Lateral views of rescued phactr4humdy/humdy; E2f1+/ (M) and exencephalic (arrow) phactr4humdy/humdy; E2f1+/+ (N) embryos. Embryonic age
is indicated in each panel.cycle than wild-type or single or double mutant cells (Dan-
nenberg et al., 2000; Sage et al., 2000), consistent with the
shortened cell cycle in humdy neural tube. Rb-deficient98 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier Incortical progenitor cells show a significant delay in termi-
nal differentiation and enhanced neurogenesis (Callaghan
et al., 1999; Ferguson et al., 2002), and p107 regulatesc.
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Phactr4 Controls Neurulation via Rb/E2F Cell Cycleneural progenitors in the embryonic and adult brain (Van-
derluit et al., 2004). The humdy mutation affects early
neural progenitors and causes a delay in differentiation
with subsequently increased neurogenesis. Although it
has been reported that Rb is not present in retinal progen-
itors in the later embryonic eye (Spencer et al., 2005), it is
of note that we observed phosphorylated and unphos-
phorylated forms of Rb in retinal progenitors at E12.5
and that Rb is detected in P0 retinal progenitors (Zhang
et al., 2004). Rb loss in the brain and retina, or loss of Rb
and p107 in the retina, causes ectopic division of differen-
tiating cells (Chen et al., 2004; Ferguson et al., 2002; Mac-
Pherson et al., 2004). This is consistent with the ectopic
division seen in the humdy neural tube and retina, al-
though this cell-cycle exit defect is more subtle in the
humdy retina compared to Rb knockout. It must also be
borne in mind that Phactr4 controls only the phosphoryla-
tion status of Rb, not Rb gene or protein levels, and hence
is different from Rb loss. Therefore, it should not be as-
sumed that the phenotypes would be the same for an
Rb hyperphosphorylation mutant versus an Rb null.
The second possibility is that Phactr4 acts through Rb-
independent pathways to regulate E2F1 activity. PP1
function in cell-cycle regulation is best studied through
Rb regulation, and the majority of genetic and physiolog-
ical evidence favors the view that the Rb family is the
most important regulator of E2F1. However, it is possible
that Phactr4-modulated PP1 activity could target other
cell-cycle regulators to control E2F1 function. For exam-
ple, cell-cycle kinases such as ATM/ATR and Chk1/2
can phosphorylate and positively regulate E2F1 activity
(Lin et al., 2001; Stevens and La Thangue, 2003; Urist
et al., 2004). Although PP1 has not been specifically impli-
cated in dephosphorylation of any E2F family members, it
is possible that reduced PP1 activity in humdy mutants
could increase E2F1 activity, independently of Rb.
Phactr4-PP1 could also indirectly affect E2F1 activity by
altering the phosphorylation state and hence activity of
cell-cycle kinases like cyclinA/CDK2 and JNK (Kishore
et al., 2003; Krek and DeCaprio, 1995; Wang et al.,
1999; Xu et al., 1994). For instance, CDC25 is an enzyme
that phosphorylates cell-cycle kinases and is also a target
of PP1. CDC25 is activated by PP1 and is an activator of
mitotic entry (Margolis et al., 2003; Rudolph, 2007). How-
ever, the humdy phenotype is opposite of what might be
expected, as PP1 function is inhibited in humdy mutants,
which should lead to inhibition of CDC25 activity and a
defect in mitotic entry, rather than acceleration of the
cell cycle.
Many future experiments will be required to distinguish
the Rb-dependent and Rb-independent regulation of
E2F1 activity, and to determine the full range of Phactr4
functions and in vivo targets. The phactr4humdy missense
mutation in the PP1 binding site provides novel insight
into the critical control of embryonic cell-cycle regulation
and highlights another important in vivo role for Phactr4
in providing PP1, a phosphatase with a broad range of
targets, specificity for its target Rb, as well as perhaps
other critical cell-cycle regulators.DeModel for Phactr4 Function in Temporal and Spatial
Regulation of Proliferation in the Neural Tube
and Retina
Our studies also highlight the interesting conclusion that
Phactr4 controls a temporal and spatial specific transition
in proliferation. Figure 7 presents a model that incorpo-
rates the restricted pattern of Phactr4 expression at the
time of cranial neural tube closure, the regionally regulated
proliferation, and the phosphorylation state of PP1 and Rb
in the ventral and dorsal halves of wild-type and humdy
mutant neural tubes.
In wild-type embryos at the time of neural tube closure,
Phactr4 expression is strongest in the ventral neural tube.
There is differential proliferation, with more cells cycling in
the dorsal half of the neural tube relative to the ventral half.
Dorsally, more cells express a form of PP1 phosphory-
lated on an inhibitory site, which decreases PP1’s phos-
phatase activity. There is a corresponding increase in
hyperphosphorylated Rb, and this correlates with a higher
rate of proliferation in the dorsal neural tube. In contrast,
on the ventral half, Phactr4 is expressed and available to
bind PP1 and tether it in the cytoplasm through the binding
of Phactr4 to actin. PP1 binding to Phactr4 retains PP1 in
an active state, as it does not undergo inhibitory phos-
phorylation. Thus, during the cell cycle when PP1 shuttles
to the nucleus of the ventral cells, it can dephosphorylate
and activate Rb such that Rb can bind E2F and prevent
cell-cycle progression.
In the humdymutant at the time of neural closure, there
is a significant increase in number of proliferating cells in
the ventral neural tube. The humdy mutation does not af-
fect Phactr4 protein expression or subcellular localization
but specifically disrupts its ability to bind to PP1, and this
leads to acquisition of an inhibitory phosphorylation on
PP1. This decreases the ability of PP1 to dephosphorylate
Rb, and hence Rb becomes hyperphosphorylated and
can no longer bind E2F. This leads to abnormal activation
of E2F targets and cell-cycle progression. Thus, loss of
Phactr4 binding to PP1 results in misregulated prolifera-
tion in the ventral neural tube due to the ensuing cascade
of E2F misregulation.
A day after neural tube closure,Phactr4 expression is no
longer restricted within the neural tube and instead is
broadly expressed in both dorsal and ventral halves. In
humdy mutants, there is now misregulated proliferation
throughout the dorsoventral aspects of the neural tube
at E10.5, followed by massive overgrowth of the neural
tissue and increased neurogenesis. Phactr4 is required
to regulate both cell-cycle length and exit from the cell
cycle. Phactr4 is also expressed in the eye, and this tissue
is affected in the humdymutant with similar misregulation
of PP1 and Rb phosphorylation and abnormal prolifera-
tion. Therefore, our in vivo studies demonstrate the func-
tional importance of Phactr4 in regulating embryonic
proliferation in time and space.
Our studies conclusively show that the cell-cycle defect
in humdy mutants is the cause of exencephaly, as neural
tube closure and proliferation defects are rescued by
loss of E2f1. Although closure of the neural tube and opticvelopmental Cell 13, 87–102, July 2007 ª2007 Elsevier Inc. 99
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Phactr4 Controls Neurulation via Rb/E2F Cell CycleFigure 7. Model for Phactr4 Regulation of PP1 and Rb Activity in the Dorsal and Ventral Neural Tube during Neural Tube Closure
Phactr4 RNA is normally localized to the ventral neural tube at E9.5 in a region of reduced proliferation. The phactr4humdymutation causes abnormally
increased proliferation in the ventral neural tube during neurulation. The Phactr4humdy protein cannot bind PP1, and this leads to an inhibitory phos-
phorylation of PP1, decreasedPP1phosphatase activity, Rb hyperphosphorylation, and cell-cycle progression in thephactr4humdy ventral neural tube.fissure are very different processes, our data indicate that
misregulated proliferation is also the cause of retinal colo-
boma in humdy mutants. Regionalized proliferation along
the dorsoventral axis in the cranial neural tube at the time
of closure has been noted but its importance has not been
established (Copp et al., 2003). Our work provides what is,
to our knowledge, the first identification of a molecular
regulator of this differential proliferation. These studies
therefore demonstrate that spatially regulated prolifera-
tion is necessary for cranial neural tube closure and that
Phactr4 is a cell-cycle regulator specifically required for
this controlled proliferation.
EXPERIMENTAL PROCEDURES
Mouse Strains, Genotyping, and humdy Mutation Identification
humdywas identified in a screen for recessive ENU-inducedmutations
that cause morphological abnormalities at E12.5 (Garcia-Garcia et al.,
2005; Kasarskis et al., 1998; Zohn et al., 2005). The humdy mutation
was inducedwith ethyl nitrosourea on aC57BL/6J genetic background
and outcrossed to C3H3B/FeJ for more than ten generations to estab-
lish a congenic line. No phenotypic variation was observed on the
different backgrounds. humdy was mapped between Massachusetts
Institute of Technology (MIT) SSLP markers D4 mit203 and D4
mit204. For high-resolution mapping, additional markers were gener-
ated: D4ski4010L (50-TGGTGGCAGCTCTTACTCCT-30 ), D2ski4010R100 Developmental Cell 13, 87–102, July 2007 ª2007 Elsevier(50-TTTGCTTACAAAGGGGGATG-30), D4ski55-50L (50-CAAGTGTA
CCCATGCACACC-30), and D4ski55-50R (50-TCATGGCCAGTGAA
GTGTTC-30). The humdy mutation was identified by sequencing
Phactr4 cDNAs generated by RT-PCR (SuperScript One-Step RT-
PCR; Invitrogen) using RNA from E10.5 humdy/humdy and C57BL/
6J embryos. Mouse embryonic stem (ES) cell line RRA075 has
a gene-trap insertion in Phactr4 (http://baygenomics.ucsf.edu/). Mice
were generated by blastocyst injection of RRA075 ES cells and kept
on C3H background and genotyped by PCR with lacZ primers (Liu
et al., 1999a) and/or MIT marker D4 mit204. Mice lacking E2f1 were
a gift from Dr. J. DeGregori.
Histology and RNA and Protein Localization and Quantification
b-galactosidase activity in whole-mount embryos from the gene-trap
line was detected by X-gal staining (Eggenschwiler et al., 2001). Sec-
tion RNA in situ hybridization (Holmes and Niswander, 2001) results
were identical with digoxygenin-labeled probes from two regions of
Phactr4. Antibody stainings on fixed frozen 10 mm sections of E8.5–
E14.5 embryos (Timmer et al., 2002) used anti-Ki67 (Novocastra),
anti-PH3, anti-cortactin (Upstate), anti-TuJ1 (Covance), anti-p27 (BD
Biosciences), anti-F-actin (Chemicon), anti-PERM, anti-PS608Rb,
anti-PS807/811Rb, anti-PT320 (Cell Signaling), and anti-MCM2
(Transduction Laboratories) antibodies. Anti-PP1a and anti-Phactr1
antibodies were kind gifts from Drs. P. Allen and P. Greengard. The
anti-Phactr4 peptide (TTKTANDQREKTVSL) antibody was generated
by Bio-Synthesis, Incorporated. BrdU (1 mg/20 g body weight; Sigma)
was injected intraperitoneally 4 hr before sacrifice and detected with
anti-BrdU antibody (Roche). For nuclear/cytoplasmic fractionation,Inc.
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Phactr4 Controls Neurulation via Rb/E2F Cell Cyclewild-type and humdy cranial regions were dissected, homogenized in
hypotonic buffer with detergent and 1mMDTT, and then processed as
described in the Active Motif nuclear extract kit. Band intensity was
quantified with the Bio-Rad Quantity One program.
Mitotic cell number (PH3-positive) was quantified in sections from
E9.5 wild-type or humdy cranial neural tube and E12.5 retina. Using
age-matched littermates and the Wilcoxon signed rank test, the aver-
age difference between wild-type and mutant dorsal neural tube was
not significant (p value = 0.67), whereas in the humdy ventral neural
tube there was a statistically significant (p = 0.046) increase in mitotic
cells. The average difference between wild-type andmutant retina was
4.8 (p = 0.042). There was no difference between humdy dorsal versus
ventral neural tube using the Mann-Whitney U test (nonparametric
t test; p value = 0.936).
Cumulative BrdU Assay
Cumulative BrdU labeling in E10.5 embryos was performed by
repeated intraperitoneal injections of BrdU into pregnant females at
2 hr intervals. Samples were fixed 30 min after injection and the time
points were 30 min, 2 hr 30 min, 4 hr 30 min, 6 hr 30 min, and 8 hr
30 min, and six embryos (wild-type or mutant) per time point were
analyzed. The proportion of BrdU-stained nuclei of neuroprogenitors
was used to calculate Tc (total cell-cycle length) and Ts (S phase) using
the Excel program kindly provided by Drs. R. Nowakowski and F.
Calegari (Nowakowski et al., 1989).
Yeast Two-Hybrid Assays
Wild-type and humdy mutant Phactr4 constructs were ligated into
pPC86, a GAL4 activation domain fusion vector, and PP1a (a gift of
Drs. P. Allen and P. Greengard) was ligated into pPC62, a GAL4
DNA-binding domain fusion vector. Yeast two-hybrid experiments
were performed as per the Clontech Matchmaker Gal4 two-hybrid
system.
Coimmunoprecipitation and Cell Cultures
Wild-type and humdy mutant Phactr4 constructs were ligated into
mammalian expression vector pCMV-Tag3 (Stratagene). HEK293T
cells were transfected with plasmid DNA using Effectene transfection
reagent (QIAGEN) and grown for at least 2 days. Transfected cells were
lysed and total protein (1 mg) was used for immunoprecipitation (Allen
et al., 2004) with anti-Myc (Cell Signaling), anti-actin, and anti-PP1a.
HeLa cells were transfected with Myc-tagged wild-type Phactr4
constructs and images were analyzed after staining with anti-Myc,
anti-PP1a, anti-PP1b, and anti-PP1g (Chemicon).
Supplemental Data
Supplemental Data include three figures and are available at http://
www.developmentalcell.com/cgi/content/full/13/1/87/DC1/.
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